Ralliant Corporation (RAL) to Distribute Quarterly Dividend of $0.05 on September 23rd

Ralliant Corporation (NYSE:RAL) announced a quarterly dividend on Tuesday, August 4th. Stockholders of record on Tuesday, September 8th will be given a dividend of 0.05 per share on Wednesday, September 23rd. This represents a c) annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Tuesday, September 8th.

Ralliant Stock Up 1.1%

Shares of NYSE RAL opened at $63.46 on Friday. The stock has a market capitalization of $7.02 billion, a P/E ratio of -5.85, a PEG ratio of 2.36 and a beta of 1.54. Ralliant has a one year low of $37.27 and a one year high of $75.41. The firm’s 50 day simple moving average is $67.52 and its two-hundred day simple moving average is $57.10. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00.

Ralliant (NYSE:RAL) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, analysts expect that Ralliant will post 2.87 EPS for the current fiscal year.

Insiders Place Their Bets

In other Ralliant news, SVP Karen Bick sold 6,062 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the sale, the senior vice president owned 31,668 shares of the company’s stock, valued at $2,280,096. This trade represents a 16.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara Newcombe sold 12,936 shares of the business’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the transaction, the chief executive officer owned 251,967 shares in the company, valued at $18,088,710.93. The trade was a 4.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of RAL. Cetera Investment Advisers bought a new stake in shares of Ralliant in the 2nd quarter worth approximately $700,000. Russell Investments Group Ltd. purchased a new stake in Ralliant in the second quarter worth $1,465,000. EverSource Wealth Advisors LLC purchased a new stake in Ralliant in the second quarter worth $39,000. First Trust Advisors LP bought a new stake in Ralliant in the second quarter valued at $2,013,000. Finally, Federated Hermes Inc. bought a new stake in Ralliant in the second quarter valued at $326,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.